Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30891547 | 1.00 | LMNA (0.35) | LMNAACE2CYP3A4ALOX15MEN1 | |
| SCHEMBL21986506 | 1.00 | LMNA (0.35) | LMNAACE2CYP3A4ALOX15MEN1 | |
| SCHEMBL711809 | 1.00 | LMNA (0.35) | LMNAACE2CYP3A4ALOX15MEN1 | |
| SCHEMBL21542489 | 1.00 | LMNA (0.35) | LMNAACE2CYP3A4ALOX15MEN1 | |
| SCHEMBL31538249 | 1.00 | LMNA (0.35) | LMNAACE2CYP3A4ALOX15MEN1 | |
| SCHEMBL4760709 | 0.84 | PTPN1 (0.36) | LMNACYP3A4ALOX15MEN1MAPK1 | |
| SCHEMBL11490212 | 0.79 | LMNA (0.39) | LMNACYP3A4ALOX15MEN1MAPK1 | |
| SCHEMBL16053413 | 0.79 | LMNA (0.39) | LMNACYP3A4ALOX15MEN1MAPK1 | |
| SCHEMBL25225654 | 0.78 | LMNA (0.32) | LMNACYP3A4ALOX15MEN1MAPK1 | |
| SCHEMBL15012463 | 0.77 | LMNA (0.42) | LMNACYP3A4ALOX15MEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421475-B2 | High performing, high impact bloom accord with a top, medium, and base note mixture | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-23 | — | — | US | claimed |
| WO-2025051371-A1 | A FRAGRANCE PASTILLE | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | claimed |
| WO-2025045353-A1 | A FRAGRANCE POD | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| WO-2025045354-A1 | A FRAGRANCE TABLET | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| EP-4516118-A2 | USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE | Symrise AG (DE) | 2025-03-05 | — | — | EP | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-3665163-B1 | USE OF AMBROCENIDE® FOR ENHANCING THE FRAGRANCE OF LILLIES OF THE VALLEY | SYMRISE AG (DE) | 2024-12-25 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| CN-118059279-A | Apparatus and method for reducing malodor on surfaces | 宝洁公司 | 2024-05-24 | — | — | CN | claimed |
| CN-111050855-B | Mixtures comprising enantiomerically pure Ambrocenide DEG C | 西姆莱斯有限公司 | 2024-04-26 | — | — | CN | claimed |
| US-20080182774-A1 | MIXTURES CONTAINING 3-(4-METHYLCYCLOHEX-3-ENYL)BUTYRALDEHYDE AND 2,6-DIMETHYL-7-OCTEN-2-OL | SYMRISE GMBH & CO. KG (DE) | 2008-07-31 | — | — | US | claimed |
| EP-1947166-A1 | Mixtures of 3-(4-methyl-cyclohex-3-enyl)-butyraldehyde and Ambrocenide and their uses and method | Symrise GmbH & Co. KG (DE) | 2008-07-23 | — | — | EP | claimed |
| EP-1942178-A1 | Mixtures of 3-(4-Methyl-cyclohex-3-enyl)-butyraldehyde and 2,6-Dimethyl-7-octen-2-ol | Symrise GmbH & Co. KG (DE) | 2008-07-09 | — | — | EP | claimed |
| US-20080161224-A1 | MIXTURES OF 3-(4-METHYLCYCLOHEX-3-ENYL)BUTYRALDEHYDE AND AMBROCENIDE® AND CORRESPONDING USES AND METHODS | SYMRISE GMBH & CO. KG (DE) | 2008-07-03 | — | — | US | claimed |
| WO-2007073953-A1 | PERFUME COMPOSITIONS CONTAINING 3-(4-METHYLCYCLOHEX-3-ENYL)BUTYRALDEHYDE AND 1,8-P-MENTHADIENE | SYMRISE GMBH & CO. KG (DE) | 2007-07-05 | — | — | WO | claimed |
| US-5726345-A | Process for perfuming textiles | FIRMENICH S.A. (CH) | 1998-03-10 | — | — | US | claimed |
| US-5649979-A | LAUNDERING IN PRESENCE OF ESTER COMPOUND WHICH RELEASES FRAGRANT ALCOHOL, ALDEHYDE OR KETONE | FIRMENICH S.A. (CH) | 1997-07-22 | — | — | US | claimed |
| US-4337363-A | Process for the preparation of 3-(4-methyl-3-cyclohexen-1-yl) butyraldehyde | RUHRCHEMIE AKTIENGESELLSCHAFT (DE) | 1982-06-29 | — | — | US | claimed |
| EP-0053716-A1 | Terpene ethers, their production and use, and perfume compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1982-06-16 | — | — | EP | claimed |
| EP-0008459-B1 | PROCESS FOR THE PRODUCTION OF 3-(4-METHYL-3-CYCLOHEXENE-1-YL)-BUTYRALDEHYDE | Ruhrchemie Aktiengesellschaft (DE) | 1982-04-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161224-A1 | MIXTURES OF 3-(4-METHYLCYCLOHEX-3-ENYL)BUTYRALDEHYDE AND AMBROCENIDE® AND CORRESPONDING USES AND METHODS | OR51E2, DECR1, OR10J3 | LMNA 812/4885ACE2 1453/4885CYP3A4 101/4885 |
| US-20080182774-A1 | MIXTURES CONTAINING 3-(4-METHYLCYCLOHEX-3-ENYL)BUTYRALDEHYDE AND 2,6-DIMETHYL-7-OCTEN-2-OL | DLD, RIOX2, MDH2 | LMNA 390/4885ACE2 1677/4885CYP3A4 719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.